Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sub-anesthetic esketamine for recovery after laparoscopic hysterectomy
ChiCTR2100049857Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain, major depressive disorder (MDD) and Delayed postoperative recovery (DPR) (2 arms), sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: Postoperative recovery quality. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postoperative painmajor depressive disorder (MDD)Delayed postoperative recovery (DPR)
Beyond the preview
Go deeper on ChiCTR2100049857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049857.